🇺🇸 FDA
Patent

US 10570151

Biologically active molecules, conjugates thereof, and therapeutic uses

granted A61KA61K31/5365A61K47/68033

Quick answer

US patent 10570151 (Biologically active molecules, conjugates thereof, and therapeutic uses) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/5365, A61K47/68033, A61K47/6849, A61K47/6855